| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
|
Seruga, B.
|
|
|
21 |
7 |
p. 1411-1418
|
artikel
|
| 2 |
An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
|
Kozloff, M.
|
|
|
21 |
7 |
p. 1436-1441
|
artikel
|
| 3 |
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
|
Tabernero, J.
|
|
|
21 |
7 |
p. 1537-1545
|
artikel
|
| 4 |
Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
|
Foley, K.A.
|
|
|
21 |
7 |
p. 1455-1461
|
artikel
|
| 5 |
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
|
Paccagnella, A.
|
|
|
21 |
7 |
p. 1515-1522
|
artikel
|
| 6 |
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study
|
Marino, P.
|
|
|
21 |
7 |
p. 1448-1454
|
artikel
|
| 7 |
Development of a new G-CSF product based on biosimilarity assessment
|
Gascon, P.
|
|
|
21 |
7 |
p. 1419-1429
|
artikel
|
| 8 |
Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance
|
Li, R.J.
|
|
|
21 |
7 |
p. 1506-1514
|
artikel
|
| 9 |
Economic evaluation of docetaxel–gemcitabine versus vinorelbine–cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis
|
Maniadakis, N.
|
|
|
21 |
7 |
p. 1462-1467
|
artikel
|
| 10 |
Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK
|
Logman, J.F.S.
|
|
|
21 |
7 |
p. 1529-1536
|
artikel
|
| 11 |
Editorial board
|
|
|
|
21 |
7 |
p. ii-iii
|
artikel
|
| 12 |
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
|
Blohmer, J.-U.
|
|
|
21 |
7 |
p. 1430-1435
|
artikel
|
| 13 |
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC
|
Loriot, Y.
|
|
|
21 |
7 |
p. 1559-1560
|
artikel
|
| 14 |
Gain, but what, how much and at what cost?
|
Schrijvers, Dirk
|
|
|
21 |
7 |
p. 1562-1563
|
artikel
|
| 15 |
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
|
Ciruelos, E.M.
|
|
|
21 |
7 |
p. 1442-1447
|
artikel
|
| 16 |
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice
|
Santini, D.
|
|
|
21 |
7 |
p. 1565
|
artikel
|
| 17 |
High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients
|
Pavese, I.
|
|
|
21 |
7 |
p. 1523-1528
|
artikel
|
| 18 |
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid
|
Terpos, E.
|
|
|
21 |
7 |
p. 1561-1562
|
artikel
|
| 19 |
In this issue
|
|
|
|
21 |
7 |
p. 1389
|
artikel
|
| 20 |
Looking for efficiency rather than efficacy in randomized controlled trials in oncology
|
Floriani, I.
|
|
|
21 |
7 |
p. 1391-1393
|
artikel
|
| 21 |
New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma
|
Zucali, P.A.
|
|
|
21 |
7 |
p. 1560-1561
|
artikel
|
| 22 |
Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
|
Luminari, S.
|
|
|
21 |
7 |
p. 1492-1499
|
artikel
|
| 23 |
Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support
|
Castagna, L.
|
|
|
21 |
7 |
p. 1482-1485
|
artikel
|
| 24 |
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
|
Bari, A.
|
|
|
21 |
7 |
p. 1486-1491
|
artikel
|
| 25 |
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study
|
Martin-Broto, J.
|
|
|
21 |
7 |
p. 1552-1557
|
artikel
|
| 26 |
Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients
|
Janus, N.
|
|
|
21 |
7 |
p. 1395-1403
|
artikel
|
| 27 |
Second cancers after testicular cancer diagnosed after 1980 in Sweden
|
Hemminki, K.
|
|
|
21 |
7 |
p. 1546-1551
|
artikel
|
| 28 |
Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma
|
Kodaira, M.
|
|
|
21 |
7 |
p. 1563-1565
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
21 |
7 |
p. iv-v
|
artikel
|
| 30 |
Taking care of smoker cancer patients: a review and some recommendations
|
Mazza, R.
|
|
|
21 |
7 |
p. 1404-1409
|
artikel
|
| 31 |
The indolent course and high incidence of t(14;18) in primary duodenal follicular lymphoma
|
Mori, M.
|
|
|
21 |
7 |
p. 1500-1505
|
artikel
|
| 32 |
Transesophageal endoscopic ultrasound-guided fine-needle aspiration for the mediastinal staging of extrathoracic tumors: a new perspective
|
Peric, R.
|
|
|
21 |
7 |
p. 1468-1471
|
artikel
|
| 33 |
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
|
Vermaat, J.S.
|
|
|
21 |
7 |
p. 1472-1481
|
artikel
|
Tijdschrift beschrijving